Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H van Raalte

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
The Netherlands Journal of Medicine|March 25, 2014
Steroid diabetes: from mechanism to treatment?D H van Raalte, M Diamant
European Journal of Clinical Investigation|February 10, 2009
Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?D H van Raalte, D M Ouwens, M Diamant
The Netherlands Journal of Medicine|May 22, 2014
Unexpected diagnosis of visceral leishmaniasis in a patient presenting with an infected ICD leadD H van Raalte, H M Wesselius, G de Klerk
Diabetes, Obesity & Metabolism|July 15, 2011
Dipeptidyl peptidase-4 inhibitors and preservation of pancreatic islet-cell function: a critical appraisal of the evidenceR E van Genugten, D H van Raalte, M Diamant
Diabetes, Obesity & Metabolism|December 11, 2012
Extra-pancreatic effects of incretin-based therapies: potential benefit for cardiovascular-risk management in type 2 diabetesR E van Genugten, D L Möller-Goede, D H van Raalte, et al.
Nederlands Tijdschrift Voor Tandheelkunde|June 10, 2026
[Diabetes mellitus: new insights and developments]S T Jagroep, D H van Raalte, E W Meesters, et al.
Diabetologia|November 27, 2012
Postprandial microvascular function deteriorates in parallel with gradual worsening of insulin sensitivity and glucose tolerance in men with the metabolic syndrome or type 2 diabetesR E van Genugten, E H Serné, M W Heymans, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|February 6, 2021
Intestinal microbiota and diabetic kidney diseases: the Role of microbiota and derived metabolites inmodulation of renal inflammation and disease progressionC M Mosterd, M Kanbay, B J H van den Born, et al.
Diabetes & Metabolism|December 10, 2019
Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: Results of a double-blind randomized trial in patients with type 2 diabetesE J M van Bommel, H Herrema, M Davids, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 14, 2012
Angiopoietin-like protein 4 is differentially regulated by glucocorticoids and insulin in vitro and in vivo in healthy humansD H van Raalte, M Brands, M J Serlie, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The Netherlands Journal of Medicine|March 25, 2014
Steroid diabetes: from mechanism to treatment?D H van Raalte, M Diamant
European Journal of Clinical Investigation|February 10, 2009
Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?D H van Raalte, D M Ouwens, M Diamant
The Netherlands Journal of Medicine|May 22, 2014
Unexpected diagnosis of visceral leishmaniasis in a patient presenting with an infected ICD leadD H van Raalte, H M Wesselius, G de Klerk
Diabetes, Obesity & Metabolism|July 15, 2011
Dipeptidyl peptidase-4 inhibitors and preservation of pancreatic islet-cell function: a critical appraisal of the evidenceR E van Genugten, D H van Raalte, M Diamant
Diabetes, Obesity & Metabolism|December 11, 2012
Extra-pancreatic effects of incretin-based therapies: potential benefit for cardiovascular-risk management in type 2 diabetesR E van Genugten, D L Möller-Goede, D H van Raalte, et al.
Nederlands Tijdschrift Voor Tandheelkunde|June 10, 2026
[Diabetes mellitus: new insights and developments]S T Jagroep, D H van Raalte, E W Meesters, et al.
Diabetologia|November 27, 2012
Postprandial microvascular function deteriorates in parallel with gradual worsening of insulin sensitivity and glucose tolerance in men with the metabolic syndrome or type 2 diabetesR E van Genugten, E H Serné, M W Heymans, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|February 6, 2021
Intestinal microbiota and diabetic kidney diseases: the Role of microbiota and derived metabolites inmodulation of renal inflammation and disease progressionC M Mosterd, M Kanbay, B J H van den Born, et al.
Diabetes & Metabolism|December 10, 2019
Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: Results of a double-blind randomized trial in patients with type 2 diabetesE J M van Bommel, H Herrema, M Davids, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 14, 2012
Angiopoietin-like protein 4 is differentially regulated by glucocorticoids and insulin in vitro and in vivo in healthy humansD H van Raalte, M Brands, M J Serlie, et al.
Pageof 3